NCT06893991Active, not recruiting
The Effect of Symbiotic Beverage Consumption on Lipid Profile
The Effect of Symbiotic Beverage Consumption on Lipid Profile and Nutritional Status in Overweight and Hypercholesterolemia Adults Aged Above 18 Years
Source: ClinicalTrials.gov · Last updated 25 Mar 2025
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether the synbiotic beverage "Daygurt" can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are: Does "Daygurt" significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does "Daygurt" increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does "Daygurt" lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling? The intervention group (receiving "Daygurt" plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without "Daygurt") to see if "Daygurt" provides additional benefits beyond standard dietary advice. Participants will be divided into 2 groups: Intervention group: Consume "Daygurt" daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume "Daygurt." Both groups will undergo health parameter measurements before and after the intervention, including: Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 5 Mar 2025
- Start date
- 27 Feb 2025
- Primary completion date
- 15 Jun 2025
- Lead sponsor
- Politeknik Kesehatan Kemenkes Padang
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT06893991
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 27 Feb 2025 to the primary completion date, 15 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having any drug lowering cholesterol
Other illness
- Has Allergic to dairy product
Who the study is looking for
- Cholesterol total above 200 mg/dl, or LDL Cholesterol above 100, or BMI above 25 kg/m2
- Agree to study protocols
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Health Ministry Polytechnic of Padang Coordinator of this site? Confirm its status | Padang | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.